119 related articles for article (PubMed ID: 1540091)
1. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model.
O'Riordain MG; Collins KH; Pilz M; Saporoschetz IB; Mannick JA; Rodrick ML
Arch Surg; 1992 Feb; 127(2):152-7; discussion 157-8. PubMed ID: 1540091
[TBL] [Abstract][Full Text] [Related]
2. Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine burn model.
Horgan PG; Mannick JA; Dubravec DB; Rodrick ML
Br J Surg; 1990 Apr; 77(4):401-4. PubMed ID: 2340389
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of increased tumor necrosis factor production after thermal injury. Altered sensitivity to PGE2 and immunomodulation with indomethacin.
Molloy RG; O'Riordain M; Holzheimer R; Nestor M; Collins K; Mannick JA; Rodrick ML
J Immunol; 1993 Aug; 151(4):2142-9. PubMed ID: 8345198
[TBL] [Abstract][Full Text] [Related]
5. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
Pallua N; von Heimburg D
Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine activated killer cells enhance IL-2 prevention of sepsis-related death in a murine model of thermal injury.
Mendez MV; Molloy RG; O'Riordain DS; Holzheimer RG; Nestor MS; Obando A; Saporoschetz I; Schoof DD; Mannick JA; Rodrick ML
J Surg Res; 1993 Jun; 54(6):565-70. PubMed ID: 8412066
[TBL] [Abstract][Full Text] [Related]
8. Dosage and timing of anti-TNF-alpha antibody treatment determine its effect of resistance to sepsis after injury.
O'Riordain MG; O'Riordain DS; Molloy RG; Mannick JA; Rodrick ML
J Surg Res; 1996 Jul; 64(1):95-101. PubMed ID: 8806480
[TBL] [Abstract][Full Text] [Related]
9. The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response.
Rumbaugh KP; Colmer JA; Griswold JA; Hamood AN
Cytokine; 2001 Nov; 16(4):160-8. PubMed ID: 11792126
[TBL] [Abstract][Full Text] [Related]
10. Insights into the role of gammadelta T lymphocytes in the immunopathogenic response to thermal injury.
Schwacha MG; Ayala A; Chaudry IH
J Leukoc Biol; 2000 May; 67(5):644-50. PubMed ID: 10811004
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
[TBL] [Abstract][Full Text] [Related]
12. Propranolol restores the tumor necrosis factor-alpha response of circulating inflammatory monocytes and granulocytes after burn injury and sepsis.
Muthu K; He LK; Szilagyi A; Stevenson J; Gamelli RL; Shankar R
J Burn Care Res; 2009; 30(1):8-18. PubMed ID: 19060758
[TBL] [Abstract][Full Text] [Related]
13. Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis?
Ayala A; Kisala JM; Felt JA; Perrin MM; Chaudry IH
Arch Surg; 1992 Feb; 127(2):191-6; discussion 196-7. PubMed ID: 1540097
[TBL] [Abstract][Full Text] [Related]
14. CpG oligonucleotides activate the immune response in burned mice.
Yabuki T; Takeyama N; Tsuda M; Saitoh F; Tanaka T; Noguchi H; Nakatani T
J Surg Res; 2010 Jun; 161(1):111-8. PubMed ID: 19540526
[TBL] [Abstract][Full Text] [Related]
15. Burn injury and pulmonary sepsis: development of a clinically relevant model.
Davis KA; Santaniello JM; He LK; Muthu K; Sen S; Jones SB; Gamelli RL; Shankar R
J Trauma; 2004 Feb; 56(2):272-8. PubMed ID: 14960967
[TBL] [Abstract][Full Text] [Related]
16. Effects of resveratrol on the treatment of inflammatory response induced by severe burn.
Tao K; Bai X; Jia W; Liu Y; Zhu X; Han J; Dong M; Li J; Chen D; Hu D
Inflammation; 2015; 38(3):1273-80. PubMed ID: 25586484
[TBL] [Abstract][Full Text] [Related]
17. The effect of interleukin 1 alpha on survival in a murine model of burn wound sepsis.
Silver GM; Gamelli RL; O'Reilly M; Hebert JC
Arch Surg; 1990 Jul; 125(7):922-5. PubMed ID: 2369319
[TBL] [Abstract][Full Text] [Related]
18. Severity of burn injury and sepsis determines the cytokine responses of bone marrow progenitor-derived macrophages.
Cohen MJ; Carroll C; He LK; Muthu K; Gamelli RL; Jones SB; Shankar R
J Trauma; 2007 Apr; 62(4):858-67. PubMed ID: 17426540
[TBL] [Abstract][Full Text] [Related]
19. Recombinant interleukin-2 (rIL-2) improves immune response and host resistance to septic challenge in thermally injured mice.
Gough DB; Moss NM; Jordan A; Grbic JT; Rodrick ML; Mannick JA
Surgery; 1988 Aug; 104(2):292-300. PubMed ID: 3261049
[TBL] [Abstract][Full Text] [Related]
20. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury.
Shelley O; Murphy T; Paterson H; Mannick JA; Lederer JA
Shock; 2003 Aug; 20(2):123-9. PubMed ID: 12865655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
